A detailed history of State Street Corp transactions in Sc Pharmaceuticals Inc. stock. As of the latest transaction made, State Street Corp holds 648,256 shares of SCPH stock, worth $3.56 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
648,256
Previous 575,266 12.69%
Holding current value
$3.56 Million
Previous $2.89 Million 2.36%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$3.51 - $5.21 $256,194 - $380,277
72,990 Added 12.69%
648,256 $2.82 Million
Q1 2024

May 15, 2024

BUY
$4.86 - $6.39 $72,627 - $95,492
14,944 Added 2.67%
575,266 $2.89 Million
Q4 2023

Feb 14, 2024

SELL
$4.7 - $6.63 $2.24 Million - $3.16 Million
-476,493 Reduced 45.96%
560,322 $3.51 Million
Q3 2023

Nov 14, 2023

BUY
$7.0 - $9.82 $148,239 - $207,958
21,177 Added 2.09%
1,036,815 $7.38 Million
Q2 2023

Aug 14, 2023

BUY
$8.94 - $11.74 $8.62 Million - $11.3 Million
964,078 Added 1869.82%
1,015,638 $10.3 Million
Q1 2023

May 15, 2023

BUY
$5.59 - $9.47 $136,955 - $232,015
24,500 Added 90.54%
51,560 $467,000
Q4 2022

Feb 14, 2023

BUY
$4.02 - $7.53 $38,993 - $73,041
9,700 Added 55.88%
27,060 $194,000
Q2 2022

Aug 15, 2022

BUY
$4.3 - $6.48 $9,718 - $14,644
2,260 Added 14.97%
17,360 $84,000
Q1 2022

May 16, 2022

BUY
$3.9 - $6.11 $4,290 - $6,721
1,100 Added 7.86%
15,100 $86,000
Q3 2021

Nov 15, 2021

BUY
$4.93 - $7.15 $69,020 - $100,100
14,000 New
14,000 $93,000
Q2 2021

Aug 16, 2021

SELL
$5.19 - $7.38 $540,377 - $768,398
-104,119 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$5.65 - $7.66 $152,550 - $206,820
27,000 Added 35.01%
104,119 $692,000
Q4 2020

Feb 16, 2021

BUY
$5.17 - $9.41 $121,495 - $221,135
23,500 Added 43.83%
77,119 $408,000
Q3 2020

Nov 10, 2020

BUY
$7.12 - $8.86 $6,678 - $8,310
938 Added 1.78%
53,619 $399,000
Q2 2020

Aug 14, 2020

BUY
$7.01 - $10.96 $369,293 - $577,383
52,681 New
52,681 $388,000

Others Institutions Holding SCPH

About scPharmaceuticals Inc.


  • Ticker SCPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 27,402,100
  • Market Cap $150M
  • Description
  • scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...
More about SCPH
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.